TNFRSF9 and myeloid sarcoma: Soluble CD137 (sCD137), which is generated by differential splicing, is found at elevated levels in sera of patients with autoimmune diseases, including rheumatoid arthritis (RA) and Multiple Sclerosis (MS) (10, 11).